Cargando…

Erratum: Emerging topics in FXTAS

Detalles Bibliográficos
Autores principales:	Hall, Deborah A, Birch, Rachael C, Anheim, Mathieu, Jønch, Aia E, Pintado, Elizabeth, O’Keefe, Joan A, Trollor, Julian N, Stebbins, Glenn T, Hagerman, Randi J, Fahn, Stanley, Berry-Kravis, Elizabeth, Leehey, Maureen A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387583/ https://www.ncbi.nlm.nih.gov/pubmed/25852777 http://dx.doi.org/10.1186/s11689-015-9108-7

Ejemplares similares

Emerging topics in FXTAS
por: Hall, Deborah A, et al.
Publicado: (2014)

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Hall, Deborah A., et al.
Publicado: (2020)

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
por: Hagerman, Randi J, et al.
Publicado: (2008)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014)

Current Gaps in Understanding the Molecular Basis of FXTAS
por: Hagerman, Paul J.
Publicado: (2012)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2020)

Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS
por: Wang, Junyi, et al.
Publicado: (2021)

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2020)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin, Elber Yuksel, et al.
Publicado: (2020)

Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS?
por: Shelton, Annie L., et al.
Publicado: (2018)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2023)

Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases
por: Lechpammer, Mirna, et al.
Publicado: (2017)

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism
por: Wang, Xiao-Hong, et al.
Publicado: (2018)

Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach
por: Tosin, Michelle H. S., et al.
Publicado: (2022)

Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2023)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Developmental profiles of infants with an FMR1 premutation
por: Wheeler, Anne C., et al.
Publicado: (2016)

Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS
por: Hall, Deborah A., et al.
Publicado: (2018)

A Chinese case of fragile X-associated tremor/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS
por: Zhao, Cuiping, et al.
Publicado: (2020)

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome
por: Hessl, David, et al.
Publicado: (2019)

Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers
por: Al Olaby, Reem R., et al.
Publicado: (2018)

X-inactivation in the clinical phenotype of fragile X premutation carrier sisters
por: Hall, Deborah A., et al.
Publicado: (2016)

A Three-Generation Family with Idiopathic Facial Palsy Suggesting an Autosomal Dominant Inheritance with High Penetrance
por: Grønhøj Larsen, Christian, et al.
Publicado: (2015)

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2018)

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2018)

A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion
por: Hessl, David, et al.
Publicado: (2023)

The challenges of clinical trials in fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2013)

Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor
por: Robertson, Erin E., et al.
Publicado: (2020)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective
por: Orsucci, Daniele, et al.
Publicado: (2022)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
por: Jønch, Aia Elise, et al.
Publicado: (2012)

Targeting the r(CGG) Repeats That Cause FXTAS with Modularly Assembled Small Molecules and Oligonucleotides
por: Tran, Tuan, et al.
Publicado: (2014)

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
por: Hagerman, Randi, et al.
Publicado: (2018)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
por: Luu, Skylar, et al.
Publicado: (2020)

Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2021)

Arbaclofen in fragile X syndrome: results of phase 3 trials
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2017)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2022)

Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology
por: Wenzel, H. Jürgen, et al.
Publicado: (2019)

FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
por: Tassone, Flora, et al.
Publicado: (2012)

FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Zafarullah, Marwa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g7pbhbg3o6fei3rh0cd81ogshu